Christopher A. Seeger & David R. Buchanan Named 2007 New York Super Lawyers
October 21, 2007
Seeger Weiss LLP, one of the nation's premier plaintiffs' law firms, is pleased to announce that founding partner Christopher A. Seeger and partner David R. Buchanan have been recognized as 2007 New York Super Lawyers. Both Mr. Seeger and Mr. Buchanan are listed in the category of Class Action/Mass Torts, and Mr. Seeger is also listed in the Personal Injury Plaintiff: General and Personal Injury Plaintiff: Products categories. This is the second consecutive year in which Mr. Seeger has been named a Super Lawyer, and the first year for Mr. Buchanan. Super Lawyers names the top 5 percent of attorneys in Manhattan as chosen by their peers and through the independent research of Law & Politics, publisher of Super Lawyers.
Listing outstanding lawyers from more than 60 practice areas who have attained a high degree of peer recognition and professional achievement, Super Lawyers is compiled through an extensive, multi-step process that involves attorney surveys, candidate research, and peer evaluation by practice area. The New York Times Magazine included the list of 2007 New York Super Lawyers in a special supplement, Law & Politics has published the New York Super Lawyers - Metro Edition magazine, and all results are at www.superlawyers.com.
Mr. Seeger and Mr. Buchanan have been nationally noticed for their $47.5 million jury verdict this year against Merck & Co. in a Vioxx related personal injury lawsuit. Moreover, Mr. Seeger has been counsel in several high profile cases including the national $700 million settlement from Eli Lilly & Co. related to the use of Zyprexa, and the 2004 nationwide settlement of all PPA related injury claims resulting from the ingestion of Dexatrim. He is regularly appointed to lead counsel and executive committee positions by judges in cases nationwide, and currently co-leads the federal Vioxx Multidistrict Litigation of nearly 27,000 separate cases against Merck & Co. Mr. Buchanan's high profile litigation experience includes local and national leadership roles in the Vioxx litigation, including serving as Liaison Counsel for the 15,000 Vioxx cases pending in New Jersey. He likewise serves as Liaison Counsel for the New Jersey mass tort proceedings concerning the controversial acne medication Accutane. In 2007, Mr. Buchanan co-tried the first Accutane case concerning gastrointestinal injuries, resulting in a $2.6 million award. In addition to his work on pharmaceutical and other mass tort matters, Mr. Buchanan has substantial experience with securities and consumer class actions, including the IPO securities litigation, MCI rates litigation ($88 million settlement) and Apple Computer iMac litigation (settlement valued at $47 million). His deep experience with discovery and trial in complex litigation makes him a frequent appointment to committees leading large multidistrict proceedings.
About Seeger Weiss
Operating out of offices in New York's Financial District, Newark, NJ, Philadelphia, PA Tulsa, OK, and Los Angeles, CA, Seeger Weiss has earned a national reputation by successfully representing plaintiffs in individual, mass and class actions, and by bringing innovative solutions to tough legal challenges. Composed of more than 30 attorneys, the Firm forms an elite group of former federal and state prosecutors and trial attorneys who are alumni of some of the nation's largest and most highly respected defense firms. Collectively, the Seeger Weiss lawyers, along with their co-counsel, have recovered more than $2 billion on behalf of firm clients and class members.
- Asbestos
- Class Actions
- Commercial Litigation
- Defective Products
- Drug Injury
- Personal Injury
- Securities Fraud
- Toxic Exposure
- Accutane Side Effects
- Darvon and Darvocet
- DePuy Hip Recall
- Fosamax Femur Fractures
- Muscle Injury
- Sleeping Pill Dangers
- SSRI Birth Defects
- Topamax Birth Defects
- Transvaginal Surgical Mesh and Bladder Slings
- Tylenol Liver Damage
- Zocor/Simvastatin
Pending Settlements
